“I look forward to seeing how the cannabis industry fits into our culture globally five to 10 years from now, and I am thrilled to be a part of the community at this stage in its growth,” White told Benzinga.

Ahead of the Super Bowl, Forbes featured several former NFL players and Super Bowl champions calling for a change in the league's policy to bar its athletes from medicating with cannabis or hemp derived CBD. In a message for commissioner Roger Goodell, Cullen Jenkins said the league is "playing with people's lives, with people's well being," and called for the NFL to become a leader in cannabis.

"The NFL is a leader, a role model. If they took a step in the right direction with cannabis, other people would start to take notice and learn about the medical benefits of cannabis," he said.

GrowGeneration Corp. (OTC: GRWG), one of the largest chains of specialty hydroponic and organic garden centers, announced the acquisition of Chlorophyll, Inc., a Colorado superstore, with over 20,000 sq. ft. of warehouse, and retail space.

CEO Darren Lampert told Benzinga this transaction marks the company’s first acquisition in 2019, adding $8 million in revenue. “Adding Chlorophyll...adds one of the largest and highest volume hydroponic stores in the country. Chlorophyll has a seasoned team, and we are excited that the founders, Beau Speicher and Lee McCall will continue to support the company in a sales and business development role.”

Cannabis investment firm Treehouse Global Ventures announced the addition of Emily Paxhia of Poseidon Asset Management and Tahira Rehmatullah of MTech Acquisition Corp. (NASDAQ: MTEC) to its Senior Advisory Board, joining the firm’s founders Lindy Snider, Gaynell Rogers, and Lori Ferrara, to create a women-led marijuana investments powerhouse. It’s worth noting that both Rehmatullah and Paxhia were included in Benzinga’s recent list of “20 Women Set To Dominate The International Cannabis Space In 2019.”

One of the fund’s founders, Lindy Snider, said, “We are delighted to add Emily and Tahira to our senior advisory board and look forward to many collaborations around the country and the globe with these two gifted women leaders.”

AXIM Biotechnologies Inc. (OTC: AXIM) said the United States Patent and Trademark Office issued a patent (US 10,172,786) on oral care compositions comprising cannabinoids, including CBD and/or CBG.

“We are proud to extend AXIM’s portfolio of intellectual property with this new patent on oral care compositions comprising cannabinoids,” said John M. Huemoeller, CEO of AXIM Biotechnologies. “This patent aligns with AXIM’s strategic advantages in terms of adding additional proprietary delivery mechanisms for cannabinoid-based products and the company could benefit from its use in both our nutraceutical and pharmaceutical product development programs.”

The Flowr Corporation (OTC: FLWPF) opened up two new revenue streams. The company began selling its premium cannabis in Manitoba and announced plans to sell cannabis plant clones and seeds. Manitoba is the fifth province to carry Flowr products and dispensaries there will have access to four of Flowr’s premium strains.

A bigger opportunity may be in supplying other large growers. Flowr recently announced plans to sell clones in volume to other established Canadian growers, the new micro- or “craft” cultivators being licensed in Canada and for export, in addition to Canada’s home-grow market. The company said it can produce more than 3.2 million high quality clones annually once its cultivation facility is completed later this year.

“There’s a huge amount of cultivation space coming online in Canada and around the world over the next few years and that requires high quality starter material -- seeds or clones -- to actually start producing cannabis,” Vinay Tolia, Flowr’s co-CEO told Benzinga. “For a company like Flowr that has both great genetics and the capacity to produce a large volume of clones, it could be a very big revenue opportunity.”

RYAH Medtech, a wholly owned subsidiary of PotBotics Inc., announced a partnership with Green Revolution to launch its dose-standardizing vaporizer in Washington state. David Goldstein, CEO of Potbotics said his company is “excited to be launching RYAH in Washington state with Green Revolution. We strongly believe that the medical and wellness market in WA will greatly benefit from our dose measuring vaporizer by bringing transparency, personalization, and high quality experiences via Green Revolution's great product line."

Civilized partnered with Cannabis Club TV (CCTV) to distribute original content through their in-dispensary television network. CCTV reaches 2.6 million monthly viewers at 175 point-of-sale locations in 11 states.

CBD Unlimited (OTC: EDXC) announced a joint venture with GFe Inc. The companies are establishing a “Special Purpose Vehicle” designed to combine the technology and CBD initiatives of both companies to further accelerate their expansion into international markets. The companies said they plan to file for an IPO on a major international stock exchange.

Todd Davis, CEO of CBD Unlimited, told Benzinga, “CBD Unlimited established an international business hub based in Jamaica to allow our products and technology to be distributed from a fully legalized federal jurisdiction. Partnering with GFE based in Ontario, Canada, who has business footprints in markets in which intend to distribute was an obvious benefit... Through an Initial Public Offering of our international operations, CBD Unlimited, Inc. shareholders will gain optimal share value. Every shareholder of the company will benefit by allowing the company to properly bank its operational and infrastructure growth. GFE brings technology solutions and networking solutions that will help expedite the growth prospects of this international go to market strategy.”

True Leaf Medicine International Ltd (OTC: TRLFF), a global cannabis and hemp wellness brand for pets, expanded its retail distribution to 1,000 stores in Europe. The company added leading Italian pet supermarket chain Arcaplanet to its list of European retail partners, which includes Pets Corner UK and Das Futterhaus in Germany. True Leaf is now in more than 2,800 stores worldwide.

“True Leaf has been able to grow from a Canadian startup to a global brand because our hemp-based supplements for pets are 100 per cent legal in all markets,” said Darcy Bomford, founder and CEO of True Leaf. “CBD for pets is hot right now, but we remind consumers and investors that the CBD pet products you see on the market today are not regulated or legal. Our True Hemp product line for pets has gained worldwide popularity because it is quality-controlled, legal, safe and effective.”

Chemesis International Inc. (OTC: CADMF) subsidiary La Finca Interacviva-Arachna Med announced plans to commence construction of its GMP certified extraction facility before the end of the first quarter of this year in Bogota, Colombia.

“We are extremely pleased with La Finca and the progress it has made in such a short period of time,” said CEO Edgar Montero in statement. “The Company's certified extraction facility will allow the Company to service both domestic and international markets with a variety of finished goods, for its in house and third-party brands.”

Sarah Remesch, owner of 270M and Viride, launched a new luxury product line, New Highs CBD, aimed at helping people “achieve new heights in their lives without getting ‘high’ or intoxicated.” A women-run business, New Highs whole plant hemp-derived CBD products are grown and crafted in the USA and backed by third party lab testing by EVIO Inc (OTC: EVIO)’s  Evio Labs.

“New Highs CBD was created to elevate hemp tinctures and offer an approachable, discreet solution as part of your wellness tool kit. I’m excited to offer a premium brand to consumers who share in our mission towards the path of a productive lifestyle utilizing the healing properties of CBD,” said Remesch.

Cannabis industry consumer packaged goods company Dixie Brands and Khiron Life Sciences Corp (OTC: KHRNF), a medical cannabis company focused on Latin America, have signed a binding letter of intent to establish a 50/50 joint venture to introduce a full line of cannabis-infused products to the Latin American market. Dixie will also manufacture and distribute Khiron's Kuida brand of CBD-based cosmeceuticals in the United States, targeting the growing Hispanic population.

“The joint venture we announced this week with our partners, Khiron Life Sciences, allows Dixie the opportunity to be first to market with our diverse portfolio of cannabis-infused consumer packaged goods in one of the fastest growing cannabis markets in the world. [W]e look forward to working alongside our new partners to bring Dixie’s broad THC and CBD portfolio to the 650 million consumers throughout Latin America,” said Chuck Smith, CEO and Co-Founder of Dixie Brands Inc.